The Smith-Kettlewell Summer Institute is officially underway! This innovative program aims to equip blind and visually impaired students, recent grads, and early career researchers with advanced data skills crucial for STEM fields.
The electroretinogram (ERG) is an established technique for non-invasively reading out the layer-by-layer functioning of the human retina, providing biomarkers for a wide range of retinal and neurological diseases.
The Smith-Kettlewell Eye Research Institute played a key role at this year's International Multisensory Research Forum (IMRF) in Reno, Nevada, beginning June 17, 2024. An all-SKERI symposium "Shifting Sensory Reliance: Adaptive Strategies in Vision Impairment and Blindness."
Boston, MA – June 3, 2024 – The National Braille Press has announced that Steve Landau, founder of Touch Graphics Inc., has received the prestigious Touch of Genius Prize for 2024. This accolade is in recognition of Touch Graphics’ innovative educational product, T3 Games, which has been making significant strides in tactile literacy education.
Congratulations to Dr. Natela Shanidze for receiving a five-year NEI Research (R01) Grant on Oculomotor Demands for Target Stabilization without Central Vision.
Congratulations to Dr. Christian Sinnott for receiving the National Eye Institute (NEI | NIH) Travel Award to attend the Vision Sciences Society Conference.
Congratulations to Dr. Haydée García-Lázaro for receiving the Elsevier Vision Research Travel Award to attend the Vision Sciences Society (VSS) Conference.
The Smith-Kettlewell Eye Research Institute (SKERI) is proud to announce its extensive participation in the 24th Annual Meeting of the Vision Sciences Society (VSS), held from May 17 to May 22, 2024. This leading conference, taking place in St. Pete Beach, Florida, features a diverse array of presentations from SKERI scientists, highlighting cutting-edge research in vision science.
History has been made!
Researchers from the Smith Kettlewell Eye Research Institute are set to unveil their newest findings at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Seattle, WA on May 5th through the 9th. Their presentations promise to shed new light on various aspects of vision impairment and treatment.